Clinical trial
Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early…
NCT00109382 · University of Calgary, Other · Completed
Key facts
| NCT number | NCT00109382 |
|---|---|
| Title | Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) |
| Official title | Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) |
| Lead sponsor | University of Calgary, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Canadian Stroke Consortium (CSC) |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Transient Ischemic Attack, Stroke |
| Intervention type | Drug |
| Interventions | Aspirin, Clopidogrel, Simvastatin |
| Enrollment | 500 |
| Start date | May 1, 2003 |
| Completion | Feb 1, 2007 |
| First posted | Apr 27, 2005 |
| Last update posted | Apr 8, 2008 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: